Preventing Type 2 Diabetes in High Risk Patients: An Overview of Lifestyle and Pharmacological Measures

E-ISSN： 1873-5592|7|2|211-228

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.2, 2006-01, pp. : 211-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preventing Type 2 Diabetes Mellitus: Room for Residual Risk Reduction After Lifestyle Changes?

Current Pharmaceutical Design, Vol. 16, Iss. 34, 2010-11 ,pp. : 3839-3847

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes: An Overview of Data from PROactive

By Dormandy John

Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. : 187-202

Adis International

Access to resources Recommend Favorite

Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes

By Hankó Balázs Kázmér Margit Kumli Péter Hrágyel Zsuzsanna Samu Antal Vincze Zoltán Zelkó Romána

Pharmacy World and Science, Vol. 29, Iss. 2, 2007-04 ,pp. : 58-66

Springer Publishing Company

Access to resources Recommend Favorite

Preventing Macrovascular Disease in Patients with Type 2 Diabetes Mellitus

By Johansen O.E.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite

Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus: An Update

By Marcel M.C. Hovens Jouke T. Tamsma Edith D. Beishuizen Menno V. Huisman

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 433-445

Adis International

Access to resources Recommend Favorite